Alterity Therapeutics

<div class="ih-global-ui-overrides"></div>

<style>
  /* ==========================================================================
     InvestorHub Global UI Overrides
     Prefix: ih-
     Purpose:
       1) Hide share price / ticker widget
       2) Hide survey launcher button
       3) Hide injected timed survey popup panel
     ========================================================================== */

  /* --------------------------------------------------------------------------
     1) Hide ASX ticker / share price widget
     -------------------------------------------------------------------------- */
  #share-price {
    display: none !important;
    visibility: hidden !important;
    width: 0 !important;
    height: 0 !important;
    overflow: hidden !important;
  }

  #share-price + .h-8.w-px.bg-hubs-dividers {
    display: none !important;
  }

  /* --------------------------------------------------------------------------
     2) Hide the floating survey launcher button (bottom-right)
     (your earlier snippet)
     -------------------------------------------------------------------------- */
  .fixed.right-2.bottom-2.z-20.rounded-full.shadow-lg,
  .fixed.right-2.bottom-2.z-20 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* --------------------------------------------------------------------------
     3) Hide the timed/injected survey popup panel
     (the wrapper you pasted)
     -------------------------------------------------------------------------- */

  /* Extremely specific: matches the exact utility-class signature of that popup */
  .fixed.right-0.bottom-24.z-30.overflow-hidden.rounded-xl.shadow-xl.sm\:right-4.md\:bottom-4 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Slightly more flexible fallback (in case spacing classes change later)
     Still specific enough to avoid collateral damage */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Optional: if it ever mounts but stays in DOM, ensure it can't capture clicks */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 * {
    pointer-events: none !important;
  }
</style>

Contact Us

Governance

Press Releases [2025]

Analyst Coverage

Share Price

Events and Presentations

Announcements

Investor Overview

Investors

ATH434

Parkinsonian Diseases

Multiple System Atrophy

Pipeline

Publications & Presentations

The Science

Team

About Us

About Us Overview

Home

Synapse Sessions

Montserrat

Alterity Therapeutics CEO Dr David Stamler joined ShareCafe's Sip and Learn Webinar series on Wednesday, 19th February, presenting the company's latest developments, which include the topline results of the Phase 2 trial of ATH434 for the treatment of Multiple System Atrophy, and answering live questions from investors.

ShareCafe Sip & Learn Webinar - Alterity Therapeutics